Haloperidol prophylaxis in critically ill patients with a high risk for delirium
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Introduction: Delirium is associated with increased morbidity and mortality. We implemented a delirium prevention policy in intensive care unit (ICU) patients with a high risk of developing delirium, and evaluated if our policy resulted in quality improvement of relevant delirium outcome measures. Methods: This study was a before/after evaluation of a delirium prevention project using prophylactic treatment with haloperidol. Patients with a predicted risk for delirium of ≥ 50%, or with a history of alcohol abuse or dementia, were identified. According to the prevention protocol these patients received haloperidol 1 mg/8 h. Evaluation was primarily focused on delirium incidence, delirium free days without coma and 28-day mortality. Results of prophylactic treatment were compared with a historical control group and a contemporary group that did not receive haloperidol prophylaxis mainly due to non-compliance to the protocol mostly during the implementation phase. Results: In 12 months, 177 patients received haloperidol prophylaxis. Except for sepsis, patient characteristics were comparable between the prevention and the historical ( n = 299) groups. Predicted chance to develop delirium was 75 ± 19% and 73 ± 22%, respectively. Haloperidol prophylaxis resulted in a lower delirium incidence (65% vs. 75%, P = 0.01), and more delirium-free-days (median 20 days (IQR 8 to 27) vs. median 13 days (3 to 27), P = 0.003) in the intervention group compared to the control group. Cox-regression analysis adjusted for sepsis showed a hazard rate of 0.80 (95% confidence interval 0.66 to 0.98) for 28-day mortality. Beneficial effects of haloperidol appeared most pronounced in the patients with the highest risk for delirium. Furthermore, haloperidol prophylaxis resulted in less ICU re-admissions (11% vs. 18%, P = 0.03) and unplanned removal of tubes/lines (12% vs. 19%, P = 0.02). Haloperidol was stopped in 12 patients because of QTc-time prolongation ( n = 9), renal failure ( n = 1) or suspected neurological side-effects ( n = 2). No other side-effects were reported. Patients who were not treated during the intervention period ( n = 59) showed similar results compared to the untreated historical control group. Conclusions: Our evaluation study suggests that prophylactic treatment with low dose haloperidol in critically ill patients with a high risk for delirium probably has beneficial effects. These results warrant confirmation in a randomized controlled trial. Trial registration: clinicaltrial.gov Identifier: NCT01187667 .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ely, E. W., Inouye, S. K., Bernard, G. R., Gordon, S., Francis, J., May, L., Truman, B., Speroff, T., Gautam, S., Margolin, R., et al. (2001) · JAMA · doi:10.1001/jama.286.21.2703 · Cited by 3,210 · cited 1×
“[31-34].”
Delirium as a Predictor of Mortality in Mechanically Ventilated Patients in the Intensive Care Unit
Ely, E. W. (2004) · JAMA · doi:10.1001/jama.291.14.1753 · Cited by 3,073
Incidence, risk factors and consequences of ICU delirium
Ouimet, S., Kavanagh, B. P., Gottfried, S. B., & Skrobik, Y. (2007) · Intensive Care Medicine · doi:10.1007/s00134-006-0399-8 · Cited by 972
Delirium and its motoric subtypes: A study of 614 critically ill patients
Peterson, J. F., Pun, B. T., Dittus, R. S., Thomason, J. W. W., Jackson, J. C., Shintani, A. K., & Ely, E. W. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.00621.x · Cited by 660 · cited 2×
“Patients with delirium were divided into three subtypes [19] as measured during the complete delirium period: hyperactive (Richmond agitation sedation score (RASS) [20] +1/+4), hypoactive (RASS 0/-3), and mixed (RASS +4/-3).”
BackgroundMethodDelirium in an intensive care unit: a study of risk factors
Dubois, M.-J., Bergeron, N., Dumont, M., Dial, S., & Skrobik, Y. (2001) · Intensive Care Medicine · doi:10.1007/s001340101017 · Cited by 609 · cited 1×
“The incidence of delirium in intensive care (ICU) patients is high [2-5], up to 80%, and its occurrence is associated with prolonged duration of mechanical ventilation, increased ICU- and hospital length of stay [3,5], unplanned removal of tubes and catheters [5] and an increased mortality [5,6].”
Backgroundvan den Boogaard, M., Schoonhoven, L., Evers, A. W. M., van der Hoeven, J. G., van Achterberg, T., & Pickkers, P. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31822e9fc9 · Cited by 361
Self-citationHaloperidol use is associated with lower hospital mortality in mechanically ventilated patients*
Milbrandt, E. B., Kersten, A., Kong, L., Weissfeld, L. A., Clermont, G., Fink, M. P., & Angus, D. C. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000150743.16005.9a · Cited by 140
Cited by
Neuropathogenesis of Delirium: Review of Current Etiologic Theories and Common Pathways
Maldonado, J. R. (2013) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.09.005 · Cited by 745
Postoperative Delirium in Older Adults: Best Practice Statement from the American Geriatrics Society
Inouye, S. K., Robinson, T., Blaum, C., Busby-Whitehead, J., Boustani, M., Chalian, A., Deiner, S., Fick, D., Hutchison, L., Johanning, J., et al. (2015) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2014.10.019 · Cited by 518
Neufeld, K. J., Yue, J., Robinson, T. N., Inouye, S. K., & Needham, D. M. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14076 · Cited by 505
Page, V. J., Ely, E. W., Gates, S., Zhao, X. B., Alce, T., Shintani, A., Jackson, J., Perkins, G. D., & McAuley, D. F. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70166-8 · Cited by 410
van den Boogaard, M., Schoonhoven, L., Evers, A. W. M., van der Hoeven, J. G., van Achterberg, T., & Pickkers, P. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31822e9fc9 · Cited by 361
Self-citationMaldonado, J. R. (2017) · Critical Care Clinics · doi:10.1016/j.ccc.2017.03.013 · Cited by 325
DAS-Taskforce, Baron, R., Binder, A., Biniek, R., Braune, S. A., Buerkle, H., Dall, P., Demirakca, S., Eckardt, R., Eggers, V., et al. (2015) · Europe PMC (PubMed Central) · doi:10.3205/000223 · Cited by 319
The status of intensive care medicine research and a future agenda for very old patients in the ICU
Flaatten, H., de Lange, D. W., Artigas, A., Bin, D., Moreno, R., Christensen, S., Joynt, G. M., Bagshaw, S. M., Sprung, C. L., Benoit, D., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4718-z · Cited by 281
van den Boogaard, M., Slooter, A. J. C., Brüggemann, R. J. M., Schoonhoven, L., Beishuizen, A., Vermeijden, J. W., Pretorius, D., de Koning, J., Simons, K. S., Dennesen, P. J. W., et al. (2018) · JAMA · doi:10.1001/jama.2018.0160 · Cited by 276
Self-citationRomero-Gómez, M., Montagnese, S., & Jalan, R. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.09.005 · Cited by 253
Barbateskovic, M., Krauss, S. R., Collet, M. O., Larsen, L. K., Jakobsen, J. C., Perner, A., & Wetterslev, J. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024562 · Cited by 54
Clancy, O., Edginton, T., Casarin, A., & Vizcaychipi, M. P. (2015) · Journal of the Intensive Care Society · doi:10.1177/1751143715569637 · Cited by 38
“However, the majority of recommended management strategies to prevent delirium are non pharmacological, such as early and progressive mobilisation, sleep hygiene and environmental control measures; no specific recommendations for first line pharmaceutical options have been made as evidence is lacking or contradictory…”
Background
Metadata
- Authors
- van den Boogaard, M., Schoonhoven, L., van Achterberg, T., van der Hoeven, J. G., & Pickkers, P.
- Venue
- Critical Care
- Published
- 2013-01-17
- Volume
- 17
- Issue
- 1
- Pages
- R9-R9
- ISSN
- 1364-8535 (ISSN-L)
- OpenAlex
- W2103739643
- Cited by
- 133
- References
- 7
- FWCI
- 14.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.